Prestige Consumer Healthcare (PBH) Non-Current Deferred Tax Liability (2011 - 2025)

Prestige Consumer Healthcare's Non-Current Deferred Tax Liability history runs 15 years deep, the most recent figure standing at $449.3 million for Q4 2025.

• In Q4 2025, Non-Current Deferred Tax Liability rose 8.72% year-over-year to $449.3 million; the TTM figure through Dec 2025 stood at $449.3 million (up 8.72% YoY), while the FY2025 annual figure was $419.6 million, up 3.96% from the prior year.
• Non-Current Deferred Tax Liability was $449.3 million for Q4 2025 at Prestige Consumer Healthcare, up from $444.9 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $484.8 million in Q1 2022 to a low of $384.0 million in Q2 2023.
• Historically, Non-Current Deferred Tax Liability has averaged $429.9 million across 5 years, with a median of $433.2 million in 2021.
• The sharpest annual moves came in 2021 and 2023: Non-Current Deferred Tax Liability climbed 16.19% in 2021, then decreased 13.24% in 2023.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $444.8 million in 2021, then climbed by 2.48% to $455.8 million in 2022, then slipped by 12.87% to $397.1 million in 2023, then rose by 4.06% to $413.3 million in 2024, then gained by 8.72% to $449.3 million in 2025.
• The last three Non-Current Deferred Tax Liability figures came in at $449.3 million (Q4 2025), $444.9 million (Q3 2025), and $426.9 million (Q2 2025), per Business Quant data.